The physiological role of BRAF in the monocytic-macrophage/dendritic cell lineage remains ill-defined, but somatic BRAF and MEK mutations are increasingly found in histiocytic neoplasms and represent a target for inhibitors blocking these kinases (83). The gene discussed is BRAF; the disease is histiocytic neoplasm.